Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- Health Spending
- Health Spend Management
- High-Deductible Health Plans
- Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Pharmacy Benefit Managers (PBMs)
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Display Only
Showing 1215 Results
The State of Comparative Effectiveness Research and the Environment for Decision-Making (2011)
Comparative effectiveness research (CER) has gained in national prominence in recent years through an infusion of federal funds and passage of the Patient Protection and Affordable Care Act (PPACA),…
Synergies at Work: Realizing the Full Value of Health Investment
According to this NPC-sponsored research, employers need a sound understanding of the value that a healthy employee population brings to their businesses. Synergies at Work: Realizing the Full Value…
The Patient-Centered Outcomes Research Institute Methodology Committee: Resource Guide
In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act, broad health reform legislation that established the Patient-Centered Outcomes Research Institute (PCORI…
International Comparison of Comparative Effectiveness Research in Five Jurisdictions: Insights for the US
This article, published in the Ocotber 2010 issue of PharmacoEconomics, examines health technology assessments (HTA) in Canada, Sweden, Scotland, The Netherlands and Australia and identifies seven…
The Patient-Centered Outcomes Research Institute Resource Guide
A key provision of the Patient Protection and Affordable Care Act, the health reform legislation signed into law in March 2010, establishes the Patient Centered Outcomes Research Institute (PCORI), a…